期刊文献+

长链非编码RNA GAS5对膀胱尿路上皮癌细胞的多柔比星耐药性研究 被引量:1

Long noncoding RNA GAS5 inhibits the resistance to doxorubicin of bladder urothelial carcinoma
下载PDF
导出
摘要 目的:研究长链非编码RNA-Growth arrest-specific 5(GAS5)对膀胱尿路上皮癌(bladder urothelial carcinoma,BUC)细胞的多柔比星耐药性的调控作用。方法:实时定量PCR法检测GAS5基因在BUC组织及细胞中的表达。将GAS5基因的表达载体转染多柔比星耐药的BUC细胞T24/DOX,实时定量PCR验证转染效果。MTT法检测T24/DOX细胞对多柔比星的耐药性。应用0.5μg/ml多柔比星处理T24/DOX细胞,流式细胞仪检测T24/DOX细胞的凋亡率,Western blot法检测T24/DOX细胞中Bcl2蛋白的表达。结果:与CCCHB-2细胞相比,GAS5基因在J82和T24细胞中的表达显著下调,而其在T24/DOX细胞中表达下调更为显著。GAS5基因的表达载体能够显著上调T24/DOX细胞中GAS5基因的表达。GAS5高表达能够抑制T24/DOX细胞对多柔比星的耐药性。GAS5高表达能够显著促进多柔比星诱导的T24/DOX细胞的凋亡,并抑制抗凋亡蛋白Bcl2的表达。结论:长链非编码RNA GAS5在BUC中低表达,且与BUC的化疗耐药相关,其过表达能够抑制BUC细胞的多柔比星耐药性。 Objective: To research the regulation effects of long non-coding RNA( lncRNA) Growth arrest-specific 5( GAS5) to doxorubicin resistant bladder urothelial carcinoma( BUC) cells. Methods: The expression of GAS5 in BUC cells was detected by quantitive real-time PCR( qRT-PCR). The expression vector for GAS5 was transfected into T24/DOX cells,and the silenced effects were detected by qRT-PCR. The chemotherapy resistance of T24/DOX cells to doxorubicin was detected by MTT assay. Flow cytometry was applied to assess the apoptosis rate,and Western blot was used to detect the expression of Bcl2 protein. Results: The expression of GAS5 in T24/DOX cells was decreased significantly than that in J82 and T24 cells when compared with CCC-HB-2 cells. The expression vector for GAS5 could up-regulate GAS5 expression in T24/DOX cells. GAS5 over-expression inhibited resistance of T24/DOX cells to doxorubicin. Meanwhile,GAS5 could promote doxorubicin induced apoptosis in T24/DOX cells,and depress the expression of anti-apoptosis protein Bcl-2. Conclusion: Decreased lncRNA-GAS5 expression relating to the chemotherapy resistance,could inhibite doxorubicin resistance of BUC cells.
出处 《现代肿瘤医学》 CAS 2017年第18期2861-2865,共5页 Journal of Modern Oncology
基金 国家自然科学基金(编号:81301834 30901480)
关键词 膀胱尿路上皮癌 长链非编码RNA GAS5 化疗耐药 多柔比星 bladder urinary tract epithelial carcinoma long non-coding RNA GAS5 chemotherapy resistance doxorubicin
  • 相关文献

参考文献1

二级参考文献16

  • 1Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, et al. Inactivation of p53 and PTEN promotes invasive bladder cancer[J]. Genes Dev, 2009,23:675-680.. 被引量:1
  • 2Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification[J]. J Clin Oncol, 2006,24:5552-5564.. 被引量:1
  • 3Abraham R, Pagano F, Gomella LG, et al. Chromosomal deletions in bladder cancer:Shutting down the pathways[J]. Front Biosci, 2007,12:826-838.. 被引量:1
  • 4Knowles MA. What we could do now: molecular pathology of bladder cancer[J]. Mol Pathol, 2001,54:214-221.. 被引量:1
  • 5Tee AR, Blenis J. mTOR, translational control and human disease[J]. Semin Cell Dev Biol, 2005,16:29-37. 被引量:1
  • 6Grant S. Cotargeting survival signaling pathways in cancer[J]. J Clin Invest, 2008,118:3003-3006.. 被引量:1
  • 7Chen M, Cassidy A, Gu J, et al. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk[J]. Carcinogenesis, 2009,30:2047-2052.. 被引量:1
  • 8Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer[J]. Eur J Cancer Prev, 2001,10:7-14.. 被引量:1
  • 9Skinner DG, Stein JP, Lieskovsky G, et al. 25-year experience in the management of invasive bladder cancer by radical cystectomy[J]. Eur Urol, 1998,33:25-26.. 被引量:1
  • 10Iwenofu OH, Lackman RD, Staddon AP, et al. Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy[J]. Mod Pathol, 2008,21:231-237. 被引量:1

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部